Intelligent Bio Solutions updates outstanding shares count following warrant exercises

Intelligent Bio Solutions Inc. (NASDAQ: INBS) has announced an update to its outstanding shares count following the exercise of prefunded warrants and the issuance of restricted common stock. As of the close of business on Thursday, the company's total outstanding common shares increased to 3,316,803. This change resulted from two actions: the exercise of previously disclosed prefunded warrants to purchase 285,000 shares of common stock, and the issuance of 4,333 shares of restricted common stock under an Investor Relations and Corporate Development Advisory Agreement.

The company's common stock is listed on The Nasdaq Stock Market LLC under the symbol INBS. No other material events or financial information were disclosed in the filing. Additionally, Intelligent Bio Solutions is conducting an Interference Study as part of its efforts to secure an FDA 510(k) submission for its Intelligent Fingerprinting Drug Screening System, which involves 75 healthy adult participants.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.